Brief: Medios Sets Out Ambition 2031 €3.1 Billion Revenue And A Doubling Of EBITDA Adjusted
29/09/2026 06:34
BRIEF-Medios Sets Out Ambition 2031 €3.1 Billion Revenue And A Doubling Of EBITDA Adjusted Sept 29 (Reuters) - Medios AG ILM1k.DE:
SETS OUT AMBITION 2031: €3.1 BILLION REVENUE AND A DOUBLING OF EBITDA ADJUSTED
SETS INTERNAL NET DEBT/EBITDA CEILING AT 2.0X
NET DEBT/EBITDA AT 1.32X IN H1 2026
TARGETS REVENUE GROWTH FROM €2.10 BILLION IN 2025 TO €3.10 BILLION BY 2031
CUMULATIVE M&A CAPACITY ABOUT €325 MILLION THROUGH 2031
REPORTS 2025 EBITDA ADJUSTED OF €87 MILLION AS BASELINE FOR 2031 TARGET
TO OPERATE TWO SEGMENTS: SPECIALTY PHARMA SUPPLY AND COMPOUNDING
ANTITRUST CLEARANCES OBTAINED FOR CAESAR & LORETZ ACQUISITION; CLOSING EXPECTED SHORTLY
Further company coverage: [ILM1k.DE]
(Gdansk Newsroom)
((Reuters Messaging: Gdansk.newsroom@thomsonreuters.com ; +48 58 7696600))
Recent news on Medios AG
See all newsBrief: Luxempart: increased its stake in pharma services company Medios AG to over 20%
Europe Research Roundup: ABN Amro Bank, Kingfisher, Vodafone
Brief: Medios Completes Caelo Acquisition
Brief: Medios Sets Out Ambition 2031 €3.1 Billion Revenue And A Doubling Of EBITDA Adjusted
Germany's Medios H1 profit hit by pricing pressure; to buy 74% of Caelo to expand API